News

  • The fight to save specialist spinal cord injury care

    By Ruth Hunt It is estimated that each year there are 4,400 new cases of someone sustaining a spinal cord injury (SCI). For these people it is crucial they receive specialist treatment not only when they are first injured but as they embark on their journey living with such complex disabilities. Why SCI are such complex injuries is they involve damage to the spinal cord [...]

  • Agincare seminar highlights urgent need to bridge fragmented systems after traumatic injury

    Doctors, nurses, healthcare professionals, lawyers, insurers, case managers and care specialists came together at Agincare’s first Injury to Independence seminar to address one of the biggest challenges facing people after traumatic injury: navigating a fragmented system of services at the moment coordinated support is needed most. Held at Southampton Football Club on 12 May, the [...]

  • Empowering a young adult to redefine independence after brain injury

    A case study by Katie Turner, Unite Professionals Case Management The client was involved in a road traffic collision (RTC) whilst he was on his motorcycle vs motorcar. He sustained multiple complex fractures, the most significant being to his right femoral shaft and right femoral neck. These injuries resulted in him having an external fixator. [...]

  • The cauda equina pathway: Is GIRFT getting it right?

    By Robert Dransfield, Partner, Penningtons Manches Cooper The National Suspected Cauda Equina Syndrome (CES) Pathway published by Getting It Right First Time (GIRFT) in 2023 was intended to address long-standing delays in diagnosis and treatment of this critical condition. Since its introduction, a number of UK clinicians have published audits and service reviews examining how [...]

  • Hope House Children’s Hospice partners with Slater and Gordon

    A children’s hospice has partnered with a national law firm to ensure its vital services can reach as many families as possible. Hope House Children’s Hospice delivers care, support and counselling services to families whose children have life-limiting conditions and are not expected to live beyond 18 years of age. The hospice, in Oswestry, works [...]

  • AI partnership targets earlier MS diagnosis

    An AI partnership aims to find blood-based RNA patterns that could support earlier MS diagnosis and track disease progression. Decode Health and Circular Genomics will work together to analyse circular RNA, stable genetic molecules that may signal disease activity. The companies hope the approach could help doctors diagnose multiple sclerosis earlier and monitor how the [...]

  • Hull brain injury charity celebrates 10 year anniversary

    A Hull charity is marking 10 years of brain injury support for people across the Humber region. P.A.U.L For Brain Recovery was founded by Paul Spence in 2016, four years after he survived a life-changing traumatic brain injury following an unprovoked assault. The charity now regularly welcomes more than 300 people each month to its [...]

  • Researchers develop ‘breakthrough’ nasay spray for stroke

    A nasal spray designed to protect brain cells after stroke could offer a new prehospital emergency option, researchers say. Researchers say the approach could help slow brain cell death and buy time for clot-removing or clot-busting treatment. The spray has been developed by scientists at the University of Hong Kong, who describe it [...]

  • The power of occupation in rebuilding identity after brain injury

    By Alison Hipkiss, Lead Neuro Occupational Therapist, Cognivate Rehab Ltd. What we do is one of the most powerful ways we express who we are. Our occupations - the everyday activities that bring purpose and meaning to our lives - play a central role in shaping our identity. Identity involves how we see ourselves and [...]

  • FDA approves infusion therapy for children and older with MS

    The FDA has approved Ocrevus for children aged 10 and older in the US with relapsing-remitting MS (RRMS). In a clinical trial, the infusion therapy significantly reduced relapses and new or enlarging lesions in paediatric patients. As the second treatment approved for children and adolescents with relapsing-remitting MS, it offers a new option for patients, [...]